Education
About Us
Working with TipRanks
Follow Us
NanoViricides (NNVC)
:NNVC
NNVC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.94 - $2.50
Previous CloseN/A
Volume409.80K
Average Volume (3M)291.02K
Market Cap
$28.13M
Enterprise Value$20.92M
Total Cash (Recent Filing)$2.54M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.48
Next Earnings
Nov 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.72
Shares Outstanding16,072,000
10 Day Avg. Volume396,751
30 Day Avg. Volume291,022
Financial Highlights & Ratios
PEG Ratio-0.90
Price to Book (P/B)2.72
Price to Sales (P/S)0.00
P/FCF Ratio-2.87
Enterprise Value/Market Cap0.74
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-109.77
Enterprise Value/Ebitda-0.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NanoViricides News
Options Prices
Currently, No data available
---
Ownership Overview
6.55%
Insiders
4.18% Mutual Funds
1.96% Other Institutional Investors
84.16% Public Companies and
Individual Investors
NNVC FAQ
What was NanoViricides’s price range in the past 12 months?
NanoViricides lowest stock price was $0.94 and its highest was $2.50 in the past 12 months.
What is NanoViricides’s market cap?
NanoViricides’s market cap is $28.13M.
When is NanoViricides’s upcoming earnings report date?
NanoViricides’s upcoming earnings report date is Nov 24, 2025 which is in 122 days.
How were NanoViricides’s earnings last quarter?
Currently, no data Available
Is NanoViricides overvalued?
According to Wall Street analysts NanoViricides’s price is currently Overvalued.
Does NanoViricides pay dividends?
NanoViricides does not currently pay dividends.
What is NanoViricides’s EPS estimate?
NanoViricides’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoViricides have?
NanoViricides has 16,072,000 shares outstanding.
What happened to NanoViricides’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NanoViricides?
Currently, no hedge funds are holding shares in NNVC
Company Description
NanoViricides
NanoViricides, Inc. is a development-stage company engaged in creating nanotechnology-based antiviral therapeutics. Its primary focus is on the research and development of drugs to combat viral infections by utilizing a novel platform that deploys nanomaterials to specifically target and neutralize viruses. The company operates in the biotechnology and pharmaceuticals sector, aiming to address unmet medical needs for treatments against viral diseases such as influenza, HIV, and COVID-19.